Dimitris Stellas

2.1k total citations
50 papers, 1.5k citations indexed

About

Dimitris Stellas is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dimitris Stellas has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Immunology and 11 papers in Oncology. Recurrent topics in Dimitris Stellas's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (8 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Dimitris Stellas is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (8 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Dimitris Stellas collaborates with scholars based in Greece, United States and United Kingdom. Dimitris Stellas's co-authors include Evangelia Patsavoudi, George N. Pavlakis, Barbara K. Felber, Cristina Bergamaschi, Apostolos Klinakis, Jenifer Bear, Carol Murphy, Theodore Fotsis, Sofia Bellou and Evdoxia Karali and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Dimitris Stellas

48 papers receiving 1.5k citations

Peers

Countries citing papers authored by Dimitris Stellas

Since Specialization

Citations

This map shows the geographic impact of Dimitris Stellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitris Stellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitris Stellas more than expected).

Fields of papers citing papers by Dimitris Stellas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitris Stellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitris Stellas. The network helps show where Dimitris Stellas may publish in the future.

Co-authorship network of co-authors of Dimitris Stellas

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitris Stellas. A scholar is included among the top collaborators of Dimitris Stellas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitris Stellas. Dimitris Stellas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity 2024 ·Frontiers in Immunology ·John A. Hangasky, Rodrigo Fernández, Dimitris Stellas, (unknown), (unknown), Gary W. Ashley, Barbara K. Felber, George N. Pavlakis, Daniel V. Santi	3
2	Preclinical evaluation of modified carbon nanohorns and their complexation with insulin 2023 ·Nanoscale Advances ·Christina Stangel, (unknown), Νatassa Pippa, Dimitris Stellas, Minfang Zhang, Toshiya Okazaki, Costas Demetzos, Nikos Tagmatarchis	0
3	Discovery of New 1,4,6-Trisubstituted-1H-pyrazolo[3,4-b]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer 2023 ·Pharmaceutics ·(unknown), Nikolaos Lougiakis, Ρωξάνη Τέντα, Katerina Gioti, Stavroula Baritaki, (unknown), (unknown), Panagiotis Marakos, Nicole Pouli, Dimitris Stellas	5
4	Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population 2023 ·Cell Reports ·Dimitris Stellas, Sevasti Karaliota, (unknown), Matthew Angel, (unknown), Katherine C. Goldfarbmuren, Cristina Bergamaschi, Barbara K. Felber, George N. Pavlakis	6
5	Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC 2023 ·Frontiers in Immunology ·(unknown), Dimitris Stellas, Sevasti Karaliota, (unknown), Antonio Valentin, Cristina Bergamaschi, Konstantinos Dimas, George N. Pavlakis	13
6	Old Drug, New Delivery Strategy: MMAE Repackaged 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Dimitris Stellas, Penelope Bouziotis, Frank Rösch	4
7	Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability 2022 ·Drug Resistance Updates ·(unknown), Dimitris Stellas, Benjamin Bonavida, Stavroula Baritaki	46
8	Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques 2021 ·PLoS Pathogens ·Margherita Rosati, Mahesh Agarwal, Xintao Hu, (unknown), Dimitris Stellas, Bhabadeb Chowdhury, Jenifer Bear, Robert Burns, Duncan Donohue, Laurent Pessaint, Hanné Andersen, Mark G. Lewis, Evangelos Terpos, Meletios Α. Dimopoulos, Alexander Wlodawer, James I. Mullins, David Venzon, George N. Pavlakis, Barbara K. Felber	12
9	SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors 2021 ·European Journal of Internal Medicine ·Evangelos Terpos, Dimitris Stellas, Margherita Rosati, Theodoros Ν. Sergentanis, Xintao Hu, Marianna Politou, Vassiliki Pappa, Ioannis Ntanasis‐Stathopoulos, Sevasti Karaliota, Jenifer Bear, Duncan Donohue, Maria Pagoni, Elisavet Grouzi, Eleni Korompoki, George N. Pavlakis, Barbara K. Felber, Meletios Α. Dimopoulos	48
10	Supporting data on combined transcriptomic and phosphoproteomic analysis of BMP4 signaling in human embryonic stem cells 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Marko Hyvönen, Dimitris Stellas, Maria Syrrou, Theodore Fotsis, Carol Murphy	1
11	Carbon nanohorn/liposome systems: Preformulation, design and in vitro toxicity studies 2019 ·Materials Science and Engineering C ·Νatassa Pippa, Christina Stangel, (unknown), (unknown), Nikolaos Naziris, Dimitris Stellas, Minfang Zhang, Masako Yudasaka, Costas Demetzos, Nikos Tagmatarchis	11
12	Design and development of multi-walled carbon nanotube-liposome drug delivery platforms 2017 ·International Journal of Pharmaceutics ·Νatassa Pippa, Demetrios D. Chronopoulos, Dimitris Stellas, Rodrigo Fernández‐Pacheco, Raúl Arenal, Costas Demetzos, Nikos Tagmatarchis	24
13	Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growthin vitroandin vivo 2016 ·Cancer Biology & Therapy ·(unknown), Dimitris Stellas, (unknown), Dimitra Thomaidou, Evangelia Patsavoudi	24
14	Chimeric lipid/block copolymer nanovesicles: Physico-chemical and bio-compatibility evaluation 2016 ·European Journal of Pharmaceutics and Biopharmaceutics ·Νatassa Pippa, Dimitris Stellas, Athanasios Skandalis, Stergios Pispas, Costas Demetzos, Marcin Libera, Andrzej Marcinkowski, Barbara Trzebicka	31
15	Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging 2015 ·EJNMMI Physics ·(unknown), Gautier Laurent, (unknown), Theodoros Tsotakos, Rana Bazzi, Dimitris Stellas, Constantinos Anagnostopoulos, Lia A. Moulopoulos, Vassilis Koutoulidis, Maria Paravatou‐Petsotas, Stavros Xanthopoulos, Stéphane Roux, Penelope Bouziotis	5
16	Two novel compounds of vanadium and molybdenum with carnitine exhibiting potential pharmacological use 2014 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), Dimitris Stellas, Vassilis Psycharis, Catherine P. Raptopoulou, Alexandra Karaliota	27
17	VEGF Signals through ATF6 and PERK to Promote Endothelial Cell Survival and Angiogenesis in the Absence of ER Stress 2014 ·Molecular Cell ·Evdoxia Karali, Sofia Bellou, Dimitris Stellas, Apostolos Klinakis, Carol Murphy, Theodore Fotsis	163
18	Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment 2012 ·Anti-Cancer Agents in Medicinal Chemistry ·Dimitris Stellas, Evangelia Patsavoudi	18
19	Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits 2010 ·BMC Cell Biology ·Dimitris Stellas, (unknown), Evangelia Patsavoudi	99
20	A Critical Role for HSP90 in Cancer Cell Invasion Involves Interaction with the Extracellular Domain of HER-2 2007 ·Journal of Biological Chemistry ·(unknown), Maria Gaitanou, Dimitris Stellas, Rebecca Matsas, Evangelia Patsavoudi	131

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact